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Background
Cancer is the second leading cause of death worldwide,
and oral cancer ranks tenth among all types [1].
Chemotherapy, radiotherapy and surgery are current
therapeutic options; however these are not fully efficient.
Permanent functional impairment and aesthetic scars
are frequent [2]. In this scenario, it is crucial to find
therapeutic alternatives, including those derived from
the flora, which currently provides about 1/3 of all new
medicines. Anacardic acids, cardanols and cardols are
the main constituents of the cashew nut shell liquid
(herein referred to as “LCC”) and together, account for
90% of its composition. The liquid is an industrial by-
product, with low economic value prior to processing.
The nut, the proper fruit from the plant Anacardium
occidentale, is edible. Anacardic acids, cardols and car-
danols are made of a phenolic ring connected to a long
side chain (usually C15H31-n) that can bear several to
none insaturations. Additionally, a methyl group can be
found in the phenolic ring [3]. Apart from current
industrial uses, it has been demonstrated that some of
these compounds may exert microbicide and anti-
oxidative activities. Anacardic acid has been shown to be
cytotoxic to lung, liver and gastric tumor cells through
epigenetic mechanisms by inhibiting histone acetyl-
transferases (HATs) [4] and in a capase-independent
manner [5]. However, given the possible molecular diver-
sity obtained from LCC constituents, not all distinct LCC
derivatives have yet been fully analyzed or characterized.
Aim
The aim of the present study was to screen for compounds
with cytotoxic activity in oral cancer cells and characterize
the observed effect.
Methods
Constituents of LCC were extracted, purified and sub-
jected to chemical reactions to generate new compounds.
Oral squamous carcinoma cells (OSCC-3) were treated
with the parental and derived compounds (total of 8) at
25ng/uL for 24h, 48h and 72h, as well as with staurospor-
ine (300nM) and ethanol (diluent of compounds); as
positive and negative controls, respectively. Citotoxicity
and cell viability were measured by spectrophotometry
and crystal violet assays. To investigate dose-dependency,
treatment with compounds with promising results was
additionally carried out, at concentrations of 0, 5, 10, and
25ng/mL, and cell viability was measured. In order to
identify the type of cell death, DNA fragmentation studies
and Western Blot for caspases were performed.
Results
Of the eight compounds tested, four showed initial cyto-
toxic activity at 25ng/mL, at all incubation times analyzed.
When tested for dose-dependency, two compounds
induced, at concentrations between 10 and 25ng/mL, a
marked decrease in cell viability, which dropped from
approximately 70% to less than 20%. DNA fragmentation
assay showed that one compound induced apoptosis,
whereas its saturated counterpart did not. These results
were further expanded by western blot analyses.
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Conclusion
Compounds derived from LCC have considerable cyto-
toxic activity towards oral cancer cells. Because of their
versatility, it is possible to determine molecular motifs that
may mediate these effects. In this light, new therapeutic
agents may be developed from the compounds tested.
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